OC Ophthotech Corp. Stock: price and management transactions · United States · SEC (Form 4)Follow the Ophthotech Corp. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 2 February 2016 (Cession). Among the most active insiders: GUYER DAVID R. The full history is openly available.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 February 2016
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
▼ President · Executives · 29 Jan 2016
11,418 shares Common Stock SEC:0001104659-16-093320:0
▼ President · Executives · 29 Jan 2016
8,482 shares Common Stock SEC:0001104659-16-093320:1
▼ President · Executives · 29 Jan 2016
100 shares Common Stock SEC:0001104659-16-093320:2
◇ Chief Executive Officer · Executives · 28 Jan 2016
18,598 shares Common Stock SEC:0001104659-16-092984:0
▼ Chief Executive Officer · Executives · 28 Jan 2016
14,198 shares Common Stock SEC:0001104659-16-092984:1
▼ Chief Executive Officer · Executives · 28 Jan 2016
3,200 shares Common Stock SEC:0001104659-16-092984:2
▼ Chief Executive Officer · Executives · 28 Jan 2016
600 shares Common Stock SEC:0001104659-16-092984:3
▼ Chief Executive Officer · Executives · 28 Jan 2016
600 shares Common Stock SEC:0001104659-16-092984:4
▼ Director · Executives · 11 Jan 2016
999 shares Common Stock SEC:0001104659-16-089676:0
▼ Director · Executives · 11 Jan 2016
1,001 shares Common Stock SEC:0001104659-16-089676:1
▼ Director · Executives · 11 Jan 2016
501 shares Common Stock SEC:0001104659-16-089676:2
▼ Director · Executives · 11 Jan 2016
499 shares Common Stock SEC:0001104659-16-089676:3
◇ SVP,General Counsel,Secretary · Executives · 4 Jan 2016
1,000 shares Common Stock SEC:0001104659-16-088437:0
▼ SVP,General Counsel,Secretary · Executives · 4 Jan 2016
1,000 shares Common Stock SEC:0001104659-16-088437:1
▼ Chief Executive Officer · Executives · 4 Jan 2016
108 shares Common Stock SEC:0001104659-16-088114:5
◇ EVP, CFO, & CBO, Treasurer · Executives · 2 Jan 2016
425 shares Common Stock SEC:0001104659-16-088108:0
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
34 shares Common Stock SEC:0001104659-16-088108:1
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
24 shares Common Stock SEC:0001104659-16-088108:2
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
45 shares Common Stock SEC:0001104659-16-088108:3
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
23 shares Common Stock SEC:0001104659-16-088108:4
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
4 shares Common Stock SEC:0001104659-16-088108:5
◇ Chief Executive Officer · Executives · 2 Jan 2016
5,750 shares Common Stock SEC:0001104659-16-088114:0
▼ Chief Executive Officer · Executives · 4 Jan 2016
862 shares Common Stock SEC:0001104659-16-088114:1
▼ Chief Executive Officer · Executives · 4 Jan 2016
600 shares Common Stock SEC:0001104659-16-088114:2
▼ Chief Executive Officer · Executives · 4 Jan 2016
1,121 shares Common Stock SEC:0001104659-16-088114:3
25 of 43 declarations
Load more (18 remaining) Acerca de Ophthotech Corp. Ophthotech Corp. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades oculares. Cotiza en el NASDAQ bajo el ticker OPHT.